Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends

In 2004, the US Food and Drug Administration (FDA) controversially issued a black box warning that antidepressants were associated with an increased risk of suicidal thoughts and behaviours in people aged under 18 years. In 2007, the warning was expanded to include young adults aged under 25 years....

Full description

Bibliographic Details
Main Authors: Martin Whitely, Melissa Raven, Jon Jureidini
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2020.00478/full
id doaj-83a185e76ace4fb7ba6ffd83f9f27f00
record_format Article
spelling doaj-83a185e76ace4fb7ba6ffd83f9f27f002020-11-25T03:12:09ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402020-06-011110.3389/fpsyt.2020.00478513629Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term TrendsMartin Whitely0Melissa Raven1Jon Jureidini2John Curtin Institute of Public Policy, Curtin University, Perth, WA, AustraliaCritical and Ethical Mental Health Research Group, Robinson Research Institute, University of Adelaide, Adelaide, SA, AustraliaCritical and Ethical Mental Health Research Group, Robinson Research Institute, University of Adelaide, Adelaide, SA, AustraliaIn 2004, the US Food and Drug Administration (FDA) controversially issued a black box warning that antidepressants were associated with an increased risk of suicidal thoughts and behaviours in people aged under 18 years. In 2007, the warning was expanded to include young adults aged under 25 years. In 2005, the Australian Therapeutic Goods Administration responded to the FDA warning by requiring Product and Consumer Information leaflets to be updated to reflect the risk. However, there was considerable debate, and at times emotive backlash, in academic journals and the international media. Prominent US and Australian mental health organisations and psychiatrists challenged the FDA warning. They argued that, on balance, antidepressant use was likely to reduce the risk of suicide. Several ecological studies were cited misleadingly as evidence that decreasing antidepressant use increases suicide risk. From 2008 to 2018, Australian per-capita child, adolescent and young adult antidepressant dispensing (0–27 years of age) and suicide (0–24 years) rates have increased approximately 66% and 49%, respectively. In addition, there was a 98% increase in intentional poisonings among 5 to 19 year-olds in New South Wales and Victoria between 2006 and 2016, with substantial overlap between the most commonly dispensed psychotropics and the drugs most commonly used in self-poisoning. These results do not support claims that increased antidepressant use reduces youth suicide risk. They are more consistent with the FDA warning and the hypothesis that antidepressant use increases the risk of suicide and self-harm by young people. Causal relationships cannot be established with certainty until there is a vast improvement in post-marketing surveillance. However, there is clear evidence that more young Australians are taking antidepressants, and more young Australians are killing themselves and self-harming, often by intentionally overdosing on the very substances that are supposed to help them.https://www.frontiersin.org/article/10.3389/fpsyt.2020.00478/fullantidepressantssuicideself-harmadolescentschildrenUS Food and Drug Administration
collection DOAJ
language English
format Article
sources DOAJ
author Martin Whitely
Melissa Raven
Jon Jureidini
spellingShingle Martin Whitely
Melissa Raven
Jon Jureidini
Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends
Frontiers in Psychiatry
antidepressants
suicide
self-harm
adolescents
children
US Food and Drug Administration
author_facet Martin Whitely
Melissa Raven
Jon Jureidini
author_sort Martin Whitely
title Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends
title_short Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends
title_full Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends
title_fullStr Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends
title_full_unstemmed Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends
title_sort antidepressant prescribing and suicide/self-harm by young australians: regulatory warnings, contradictory advice, and long-term trends
publisher Frontiers Media S.A.
series Frontiers in Psychiatry
issn 1664-0640
publishDate 2020-06-01
description In 2004, the US Food and Drug Administration (FDA) controversially issued a black box warning that antidepressants were associated with an increased risk of suicidal thoughts and behaviours in people aged under 18 years. In 2007, the warning was expanded to include young adults aged under 25 years. In 2005, the Australian Therapeutic Goods Administration responded to the FDA warning by requiring Product and Consumer Information leaflets to be updated to reflect the risk. However, there was considerable debate, and at times emotive backlash, in academic journals and the international media. Prominent US and Australian mental health organisations and psychiatrists challenged the FDA warning. They argued that, on balance, antidepressant use was likely to reduce the risk of suicide. Several ecological studies were cited misleadingly as evidence that decreasing antidepressant use increases suicide risk. From 2008 to 2018, Australian per-capita child, adolescent and young adult antidepressant dispensing (0–27 years of age) and suicide (0–24 years) rates have increased approximately 66% and 49%, respectively. In addition, there was a 98% increase in intentional poisonings among 5 to 19 year-olds in New South Wales and Victoria between 2006 and 2016, with substantial overlap between the most commonly dispensed psychotropics and the drugs most commonly used in self-poisoning. These results do not support claims that increased antidepressant use reduces youth suicide risk. They are more consistent with the FDA warning and the hypothesis that antidepressant use increases the risk of suicide and self-harm by young people. Causal relationships cannot be established with certainty until there is a vast improvement in post-marketing surveillance. However, there is clear evidence that more young Australians are taking antidepressants, and more young Australians are killing themselves and self-harming, often by intentionally overdosing on the very substances that are supposed to help them.
topic antidepressants
suicide
self-harm
adolescents
children
US Food and Drug Administration
url https://www.frontiersin.org/article/10.3389/fpsyt.2020.00478/full
work_keys_str_mv AT martinwhitely antidepressantprescribingandsuicideselfharmbyyoungaustraliansregulatorywarningscontradictoryadviceandlongtermtrends
AT melissaraven antidepressantprescribingandsuicideselfharmbyyoungaustraliansregulatorywarningscontradictoryadviceandlongtermtrends
AT jonjureidini antidepressantprescribingandsuicideselfharmbyyoungaustraliansregulatorywarningscontradictoryadviceandlongtermtrends
_version_ 1724651220363116544